Met Life Investment Management, LLC Care Dx, Inc. Transaction History
Met Life Investment Management, LLC
- $18 Billion
- Q4 2024
A detailed history of Met Life Investment Management, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 31,034 shares of CDNA stock, worth $687,403. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,034
Previous 28,900
7.38%
Holding current value
$687,403
Previous $902,000
26.39%
% of portfolio
0.0%
Previous 0.01%
Shares
41 transactions
Others Institutions Holding CDNA
# of Institutions
216Shares Held
53.3MCall Options Held
53.5KPut Options Held
23.9K-
Black Rock Inc. New York, NY5.29MShares$117 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.86MShares$108 Million0.0% of portfolio
-
State Street Corp Boston, MA2.66MShares$58.9 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.41MShares$53.4 Million0.45% of portfolio
-
Bamco Inc New York, NY2.21MShares$48.9 Million0.13% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.18B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...